Deputy Minister of Commerce Ling Ji meets with Executive Vice President Lin Yiming of Danish company Novo Nordisk.

On March 20, Ling Ji, Vice Minister of Commerce and Deputy Representative for International Trade Negotiations, met with Lin Yiming, Executive Vice President of Danish Novo Nordisk, to exchange views on the company's operations in China and opportunities for open development in China. Ling Ji stated that in recent years, China's technological innovation capabilities have rapidly improved and the scale of the pharmaceutical and health industry continues to expand. China is driving high-quality economic development with new productive forces and has become a global innovation source. He hopes that Novo Nordisk will continue to deepen its presence in the Chinese market and contribute to the construction of a healthy China. Lin Yiming expressed that Novo Nordisk is optimistic about the huge market potential in China, highly appreciates the Chinese government's continuous efforts to optimize the business environment and strengthen intellectual property protection, and is willing to increase investment in China, expand local production and research and development, and help promote the vigorous development of China's pharmaceutical and health industry.